Clinical trial
Etoposide in Treating Young Patients With Relapsed Ependymoma
NCT00278252 · Children's Cancer and Leukaemia Group, Other · Unknown status
Key facts
| NCT number | NCT00278252 |
|---|---|
| Title | Etoposide in Treating Young Patients With Relapsed Ependymoma |
| Official title | Phase II Study of Intravenous Etoposide in Patients With Relapsed Ependymoma |
| Lead sponsor | Children's Cancer and Leukaemia Group, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Procedure |
| Interventions | etoposide, conventional surgery |
| Enrollment | 14 |
| Start date | Jul 1, 2001 |
| Primary completion | Jul 1, 2010 |
| First posted | Jan 18, 2006 |
| Last update posted | Aug 7, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: